Our projects are mainly related to the rational discovery of new chemical entities (NCEs) to feed the pipeline of diseases with unmet needs for therapeutic solutions.
The R&D is focused in the discovery of NCEs with first-rate drug-like and ADMET properties and ultimately in proof-of-concept in in vivo disease models. The foremost goal is to transfer the patented/patentable innovations for pharmaceutical/biotech industries.
Our mission also encompasses training of young scientists and science dissemination. In the framework of its scientific activities, the Drug Discovery Group cooperates with several national and international renowned institutions. The networking activities of the group are open for further owners and interested scientists.